Your browser doesn't support javascript.
loading
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
van de Putte, Elisabeth E Fransen; Bosschieter, Judith; van der Kwast, Theo H; Bertz, Simone; Denzinger, Stefan; Manach, Quentin; Compérat, Eva M; Boormans, Joost L; Jewett, Michael A S; Stoehr, Robert; van Leenders, Geert J L H; Nieuwenhuijzen, Jakko A; Zlotta, Alexandre R; Hendricksen, Kees; Rouprêt, Morgan; Otto, Wolfgang; Burger, Maximilian; Hartmann, Arndt; van Rhijn, Bas W G.
Affiliation
  • van de Putte EEF; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Bosschieter J; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van der Kwast TH; Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands.
  • Bertz S; Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
  • Denzinger S; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.
  • Manach Q; Department of Pathology, University of Erlangen, Erlangen, Germany.
  • Compérat EM; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
  • Boormans JL; Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris, Pierre et Marie Curie Medical School, University Paris, Paris, France.
  • Jewett MAS; Department of Pathology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris, Pierre et Marie Curie Medical School, University Paris, Paris, France.
  • Stoehr R; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
  • van Leenders GJLH; Department of Surgical Oncology (Urology), Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.
  • Nieuwenhuijzen JA; Department of Pathology, University of Erlangen, Erlangen, Germany.
  • Zlotta AR; Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
  • Hendricksen K; Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands.
  • Rouprêt M; Department of Surgical Oncology (Urology), Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.
  • Otto W; Department of Urology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
  • Burger M; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Hartmann A; Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris, Pierre et Marie Curie Medical School, University Paris, Paris, France.
  • van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
BJU Int ; 122(6): 978-985, 2018 12.
Article in En | MEDLINE | ID: mdl-29637669
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Neoplasm Grading Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2018 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Neoplasm Grading Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2018 Type: Article Affiliation country: Netherlands